"The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease.

Slides:



Advertisements
Similar presentations
TB/HIV Research Priorities: TB Preventive Therapy.
Advertisements

The Intervention Mix Sevgi O. Aral Rome, Italy May 2010.
Universal Coverage – Can we guarantee health for all? 3 – 4 October 2011, Kuala Lumpur Nossal perspective.
Restructuring the Cancer Programs and Task Force Workgroups.
Using RE-AIM as a tool for Program Evaluation From Research to Practice.
What You Will Learn From These Sessions
Rose Wilcher November 19, 2008 Strategic Considerations for Strengthening the Integration of FP and HIV Service Delivery Programs.
IAPB 9 th General Assembly Eye Health: Everyone’s Business Hyderabad, India September 17-20, 2012 Scaling up: Perspectives for VISION 2020 Prof. Don de.
Brandi Cooke Student Intern 3 rd National Summit on Preconception Health and Health Care June 12-14, 2011 Factors Affecting the Willingness of Counselors.
Program – Science Initiatives: Scope and Applications James Blanchard, MD, MPH, PhD Director, Centre for Global Public Health University of Manitoba.
WORKING TOGETHER TO PROVIDE EVIDENCE-BASED HEALTHY AGING PROGRAMS: PUBLIC HEALTH, AGING, AND UNIVERSITY COMMUNITIES Lucinda L. Bryant PhD MSHA MBA, University.
An Introduction to Operations Research and Implementation Science or How can I make my (all) health programs better? Mark Micek, MD, MPH.
Four Corners TB & HIV Conference National Native American AIDS Prevention Center October 24, 2012 Social Marketing in Native Communities.
Why Publish? Public Health Translation Research Eric Tai, MD MS Comprehensive Cancer Control Branch Division of Cancer Prevention and Control Centers for.
Outcomes of Public Health
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
STUDY PLANNING & DESIGN TO ENHANCE TRANSLATION OF HEALTH BEHAVIOR RESEARCH Lisa Klesges, Russell Glasgow, Paul Estabrooks, David Dzewaltowski, Sheana Bull.
Affirming Our Commitment: “A Nation Free of Health and Health Care Disparities” J. Nadine Gracia, MD, MSCE Deputy Assistant Secretary for Minority Health.
The Public Health Perspective: The National Diabetes and Women’s Health Action Plan Michelle D. Owens, PhD Centers for Disease Control and Prevention.
COSI How can we reach the target to halt the increase of childhood obesity by 2025?
Health Care Reform Through the Cancer Lens State and Private Sector Reforms for Hispanic Healthcare Edward E. Partridge, MD National Board President American.
Implementation Strategy for Evidence- Based Practices CIMH Community Development Team Model Pam Hawkins, Senior Associate Association for Criminal Justice.
Overview of operational research in MSF Myriam Henkens, MD, MPH International Medical Coordinator MSF London 1st of June, 2006.
Agenda Setting Input and Status Agenda Setting Input and Status.
Conducting Community Health Research
Report from SAPCC Meet: Side Event on Indian Himalayan Region SAPCCs 27 September 2013, Kohima Sustainable Mountain Development Summit, Nagaland, 2013.
Programs and Science: Seeking the Academic Mission in Global Health James Blanchard, MD, MPH, PhD Professor and Director Centre for Global Public Health.
Enabling Continuity of a Public Health ARV Treatment program in a resource limited setting: The Case of the transition of the African Comprehensive HIV/AIDS.
Nursing Research Capacity Building. Background CON –opened as 9 th College at SQU in 2008 The CON’s next challenge is promoting nursing care based on.
Work group #2 Community based services and information.
Looking Forward: Costing for Scale Up Kate Rademacher & John Bratt October 5, 2009.
Maria E. Fernandez, Ph.D. Associate Professor Health Promotion and Behavioral Sciences University of Texas, School of Public Health.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Principles and Practices: The implementation of ethical guidelines for research on HIV Geneva, 2-3 June 2003 Ethical guidelines for HIV vaccines: Generic.
The AIDS Vaccine Policy Agenda Holly J. Wong Vice President, Public Policy International AIDS Vaccine Initiative (IAVI) Vienna, Austria International AIDS.
Bridging the Research-to-Practice Gap Session 1. Session Objectives  Understand the importance of improving data- informed decision making  Understand.
 Getting Outside of the Box: Designing and Implementing Innovative Ways to Prevent Infection Willo Pequegnat, Ph.D., Salix Health Consulting/USAID Susan.
11 The CPCRN, DCPC, NCI, and the Community Guide: Areas for Collaboration and Supportive Work Shawna L. Mercer, MSc, PhD Director The Guide to Community.
Towards a Comprehensive Education Sector Response to HIV and AIDS UNESCO EFA Working Group 20 July 2006.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Disease Control Priorities 3 rd Edition REPRODUCTIVE, MATERNAL, NEWBORN & CHILD HEALTH [NAME] [AFFILIATION] [EVENT OR MEETING]
Collaboration and Coalition Building Presented by Prevention Services of ETP Inc. and DMHAS’ Prevention Unit.
Flagship Program on Health Sector Reform and Sustainable Financing.
Introduction to OR/IR: purpose and definitions Jane Kengeya-Kayondo, WHO/TDR.
Getting more value for money: working with countries and partners toward greater effectiveness and efficiency Peter Stegman, Senior Economist.
EHFG 7 October 2005 – Patient Safety & Research UK Presidency Workshop on Patient Safety, EHFG, Bad Hofgastein,7 September 2005 Kevin McCarthy, European.
Open Forum: Scaling Up and Sustaining Interventions Moderator: Carol O'Donnell, NCER
The US Preventive Services Task Force: Potential Impact on Medicare Coverage Ned Calonge, MD, MPH Chair, USPSTF.
Scottish Improvement Science Collaborating Centre Strengthening the evidence base for improvement science: lessons learned Dr Nicola Gray, Senior Lecturer,
Chapter 5 Population Health Quality and Safety Learning Objectives 1. Explain why it is difficult to monitor healthcare quality and safety at the population.
Children’s Policy Conference Austin, TX February 24, ECI as best practice model for children 0-3 years with developmental delays / chronic identified.
Implementation Science: Finding Common Ground and Perspectives Laura Reichenbach, Evidence Project, Population Council International Conference on Family.
Linkages between CDs & NCDs: The African context Dr Frank J Mwangemi ICASA 2011: 5 th December 2011 Addis Ababa, Ethiopia.
Critical Program Movement: Integration of STD Prevention with Other Programs Kevin Fenton, MD, PhD, FFPH Director National Center for HIV/AIDS, Viral Hepatitis,
Outline The Global Fund Strategy emphasizes the Key Populations
Name(s) Here Job Title(s) Here.
Where is the Implementation in Implementation Science?
National Health Strategy
Components of a National Action Plan Ala Alwan Assistant Director-General World Health Organization 1.
Overview of guidance/frameworks
Call for Action & International Initiative
Research Translation: Lessons from Dissemination and Implementation Research for Interventions Promoting Walking and Walkability August 18, am Pacific,
Daniela B. Friedman, University of South Carolina
Double-sided HIV Cascades for Key Populations
Models, Theories and Frameworks
Healthier Kids Foundation
Presentation for Second Meeting of the Global TB/HIV Working Group
The STOP TB Strategy – 2009 VISION: A TB-free world
National Health Policy and Strategic Shifts
Presentation transcript:

"The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention." Program Science in Context Sevgi O. Aral Rome, Italy May 2010

The number of articles on translation research has exploded

NIH Conferences on Dissemination and Implementation attendees9,000 attendees

Health Systems Strengthening An important component of global health

Implementation/ Delivery Science Basic Science Clinical Science Evaluation Science Adapted from James Yon Kim 2009 Keynote address to the NIH Dissemination and Implementation Science Conference.

Health Care Delivery and Implementation Science Global Health Delivery Project

Implementation Dissemination Scale-up

Evidence Based Practice (EBP) Clinical Practice Improvement (CPI) Practice Based Evidence (PBE) Best practices

“What is different in Program Science?” “This is the same thing as implementation/dissemination/ health care delivery/scale up science.” “This is the same thing as translation research.”

I.It really does NOT matter ̶ we are all after the same thing “better public health for all ̶ by whatever name you call it” II.? some differences between Program Science and other approaches? ̶ Perhaps!

“Does X intervention work for Y clinical problem?” “What is the best approach for Y clinical problem?” Joseph Matthew ̶ Indian Pediatrics March 17, 2010

“The dissemination and implementation science initiative not helpful ̶ interventions offered not feasible within the budgetary and health system capacity constraints.” Tom Farley New York City Commissioner of Health

Issues in the implementation and scale-up of scientific findings in prevention program settings Science Treatment and prevention at individual level Individual interventions Interventions evaluated at one point in time Evaluated among “eligibles” who agree to participate in study Prevention Program Control and prevent spread at population level Multiplicity of interventions Need effective interventions during all phases of epidemics Need effective interventions for all ̶ ineligibles and those who refuse to participate included

Issues in the implementation and scale-up of scientific findings in prevention program settings (cont.) Science Interventions evaluated under “ideal” conditions Sufficient financial resources The “best” human resources Interventions evaluated when first implemented Internal validity important Prevention Program May work differently under “everyday” conditions Insufficient financial resources Typical human resources Need interventions that work for the duration Generalizability important

→ Individual interventions Expensive High intensity Labor intensive Individual level Multi-session Difficult to implement Non-generalizable

Interventions that require adherence Interventions that may lead to disinhibitions in other risk behaviors

→ Gap between scientific findings and program needs. Goal: To identify science based solutions to program dilemmas who when how

Synthesize evidence Based on available intervention studies Based on program questions

Program Science Population-based Produces knowledge about policy and program interventions that have the potential to impact health at the population level Includes interventions that operate within and outside the health sector

Program Science Includes interventions that modify social determinants of morbidity Includes research into “required and achievable coverage” or reach of interventions Includes research into “incremental” or “marginal” benefits of additional interventions

Program Science “Incremental” and “marginal” costs of interventions Synergies and antagonisms across interventions Differential uptake of interventions

Program Science Issues of adherence to interventions by the population Operational research on implementation of interventions Sustainability of interventions and their routinization

Program Science Focuses on packages of interventions Considers issues of resource expansion, advocacy, and mobilization Includes evaluation and evaluation research

ScienceProgram

It’s all semantics Ready to adapt Your part of the elephant!

Thank you!